
BridgeBio Pharma BBIO
$ 71.99
-0.41%
Quarterly report 2025-Q2
added 08-05-2025
BridgeBio Pharma P/S Ratio 2011-2026 | BBIO
Annual P/S Ratio BridgeBio Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.7 | 586 | 22.3 | 16.2 | 1.01 K | 90.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 K | 16.2 | 293 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
15.1 | $ 320.5 | 0.16 % | $ 40.9 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Amarin Corporation plc
AMRN
|
1.43 | $ 15.23 | 3.25 % | $ 6.21 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
35.6 | $ 2.94 | 10.11 % | $ 165 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.57 | - | $ 8.59 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 221.09 | -0.42 % | $ 5 B | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 110.69 | 0.32 % | $ 27.2 B | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 2.66 | 8.81 % | $ 3.11 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.19 | 2.4 % | $ 1.47 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.54 | 6.07 % | $ 9.88 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.46 | -0.34 % | $ 373 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 14.66 | 0.93 % | $ 4.53 B | ||
|
Codexis
CDXS
|
4.91 | $ 1.28 | -0.88 % | $ 94 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 1.79 | 4.56 % | $ 160 M |